-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Wednesday's After-Market Session
Share
Listen to the news

Gainers

  • Akari Therapeutics (NASDAQ:AKTX) stock rose 6.8% to $0.29 during Wednesday's after-market session. The company's market cap stands at $9.9 million.
  • Moleculin Biotech (NASDAQ:MBRX) stock moved upwards by 6.28% to $4.4. The company's market cap stands at $8.8 million.
  • China SXT Pharmaceuticals (NASDAQ:SXTC) stock rose 4.25% to $0.1. The company's market cap stands at $11.6 million.
  • Milestone Scientific (AMEX:MLSS) shares increased by 3.6% to $0.3. The company's market cap stands at $22.5 million.
  • Pomdoctor (NASDAQ:POM) shares moved upwards by 3.22% to $0.32. The company's market cap stands at $37.9 million.
  • CASI Pharmaceuticals (NASDAQ:CASI) shares moved upwards by 2.94% to $1.05. The company's market cap stands at $16.1 million.

Losers

  • Inspire Veterinary (NASDAQ:IVP) stock declined by 10.2% to $0.07 during Wednesday's after-market session.
  • 60 Degrees (NASDAQ:SXTP) shares decreased by 5.67% to $0.45. The market value of their outstanding shares is at $2.2 million.
  • Beyond Air (NASDAQ:XAIR) shares decreased by 5.38% to $1.78. The market value of their outstanding shares is at $17.5 million.
  • ENvue Medical (NASDAQ:FEED) shares decreased by 3.53% to $1.64. The market value of their outstanding shares is at $2.5 million.
  • NRX Pharmaceuticals (NASDAQ:NRXP) stock declined by 2.8% to $2.09. The company's market cap stands at $63.0 million.
  • Gelteq (NASDAQ:GELS) stock declined by 2.59% to $1.13. The market value of their outstanding shares is at $8.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending